Moderna CEO can’t explain why his company owns a US patent of a SARS-CoV2 gene sequence, filed in 2016.https://t.co/ermopMmjt5#CTCCTCGGCGGGCACGTAG

— Andrew G. Huff, PhD, MS 🇺🇸 (@AGHuff) December 17, 2022